Human kallikrein

Liquid

Packaging options

11-473	Vial	1 mg

Structure : 52 kDa heavy chain and a 33 kDa light chain linked by disulfide bridges.
Formulation : 1mg in a buffer composed of 4mM sodium acetate / hydrochloride, 150mM NaCl, pH 5.3

Description of the Human kallikrein

MW(Da) : 85 000
Coef. Extinction : 1.17

Informations

Kallikrein is a glycoprotein derived from prekallikrein. It is non-covalently complexed to the high molecular weight kininogen. FXIIa activates the transformation of prekallikrein into kallikrein which will activate FXII and hydrolyze KHPM into several fragments. In fibrinolysis, kallikrein is also able to activate pro-urokinase to urokinase.

product sheet

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

My personal Space

Nouveau client

Human kallikrein

Price list, safety data sheets and notices are accessible to our registered customers.